NanoViricides, Inc. (OTC:NNVC) will speak at the 2009 Influenza Congress in Washington DC on November 19. Participating in the event will be NanoViricides CEO, Eugene Seymour, MD, MPH. Seymour will discuss the “Evolving Role of Anti-Virals” in influenza treatment.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
After a review of the company’s recent vivo studies against influenza, the company has decided to consolidate its anti-influenza drug, FluCide. FluCide is anticipated to be very effective against all forms of influenza A, including H1N1, better known as the swine flu, and H5N1 bird flu. FluCide is designed to keep the possibility of resistant strain mutations at a minimum.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
